Cargando…

A Long-Term Treatment Outcome of Abdominal Sacrocolpopexy

PURPOSE: The aim of this study was to evaluate the long-term treatment outcome and major complication rates of abdominal sacrocolpopexy (ASC). MATERIALS AND METHODS: This retrospective study included 57 Korean women who underwent ASC with mesh for symptomatic uterine or vault prolapse and attended f...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeon, Myung Jae, Moon, Yeo Jung, Jung, Hyun Joo, Lim, Kyung Jin, Yang, Hyo In, Kim, Sei Kwang, Bai, Sang Wook
Formato: Texto
Lenguaje:English
Publicado: Yonsei University College of Medicine 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2796408/
https://www.ncbi.nlm.nih.gov/pubmed/20046422
http://dx.doi.org/10.3349/ymj.2009.50.6.807
_version_ 1782175528240807936
author Jeon, Myung Jae
Moon, Yeo Jung
Jung, Hyun Joo
Lim, Kyung Jin
Yang, Hyo In
Kim, Sei Kwang
Bai, Sang Wook
author_facet Jeon, Myung Jae
Moon, Yeo Jung
Jung, Hyun Joo
Lim, Kyung Jin
Yang, Hyo In
Kim, Sei Kwang
Bai, Sang Wook
author_sort Jeon, Myung Jae
collection PubMed
description PURPOSE: The aim of this study was to evaluate the long-term treatment outcome and major complication rates of abdominal sacrocolpopexy (ASC). MATERIALS AND METHODS: This retrospective study included 57 Korean women who underwent ASC with mesh for symptomatic uterine or vault prolapse and attended follow-up visits for at least 5 years. Forty-seven women with urodynamic stress incontinence concomitantly received a modified Burch colposuspension. The long-term anatomical and functional outcomes and complication rates were assessed. RESULTS: The median follow-up was 66 months (range 60-108). Overall anatomical success rates (no recurrence of any prolapse ≥ stage II according to the pelvic organ prolapse-quantification system) were 86.0%. Urinary urgency and voiding dysfunction were significantly improved after surgery, however, recurrent stress urinary incontinence developed in 44.7% (21/47) of cases and half of them developed within 1-3 months post-op. Bowel function (constipation and fecal incontinence) and sexual function (sexual activity and dyspareunia) did not significantly change after surgery. Major complication requiring reoperation or intensive care developed in 12 (21.0%) cases. CONCLUSIONS: ASC provides durable pelvic support, however, it may be ineffective for alleviating pelvic floor dysfunction except for urinary urgency and voiding dysfunction, and it contains major complication risk that cannot be overlooked.
format Text
id pubmed-2796408
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Yonsei University College of Medicine
record_format MEDLINE/PubMed
spelling pubmed-27964082009-12-31 A Long-Term Treatment Outcome of Abdominal Sacrocolpopexy Jeon, Myung Jae Moon, Yeo Jung Jung, Hyun Joo Lim, Kyung Jin Yang, Hyo In Kim, Sei Kwang Bai, Sang Wook Yonsei Med J Original Article PURPOSE: The aim of this study was to evaluate the long-term treatment outcome and major complication rates of abdominal sacrocolpopexy (ASC). MATERIALS AND METHODS: This retrospective study included 57 Korean women who underwent ASC with mesh for symptomatic uterine or vault prolapse and attended follow-up visits for at least 5 years. Forty-seven women with urodynamic stress incontinence concomitantly received a modified Burch colposuspension. The long-term anatomical and functional outcomes and complication rates were assessed. RESULTS: The median follow-up was 66 months (range 60-108). Overall anatomical success rates (no recurrence of any prolapse ≥ stage II according to the pelvic organ prolapse-quantification system) were 86.0%. Urinary urgency and voiding dysfunction were significantly improved after surgery, however, recurrent stress urinary incontinence developed in 44.7% (21/47) of cases and half of them developed within 1-3 months post-op. Bowel function (constipation and fecal incontinence) and sexual function (sexual activity and dyspareunia) did not significantly change after surgery. Major complication requiring reoperation or intensive care developed in 12 (21.0%) cases. CONCLUSIONS: ASC provides durable pelvic support, however, it may be ineffective for alleviating pelvic floor dysfunction except for urinary urgency and voiding dysfunction, and it contains major complication risk that cannot be overlooked. Yonsei University College of Medicine 2009-12-31 2009-12-18 /pmc/articles/PMC2796408/ /pubmed/20046422 http://dx.doi.org/10.3349/ymj.2009.50.6.807 Text en © Copyright: Yonsei University College of Medicine 2009 http://creativecommons.org/licenses/by-nc/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Jeon, Myung Jae
Moon, Yeo Jung
Jung, Hyun Joo
Lim, Kyung Jin
Yang, Hyo In
Kim, Sei Kwang
Bai, Sang Wook
A Long-Term Treatment Outcome of Abdominal Sacrocolpopexy
title A Long-Term Treatment Outcome of Abdominal Sacrocolpopexy
title_full A Long-Term Treatment Outcome of Abdominal Sacrocolpopexy
title_fullStr A Long-Term Treatment Outcome of Abdominal Sacrocolpopexy
title_full_unstemmed A Long-Term Treatment Outcome of Abdominal Sacrocolpopexy
title_short A Long-Term Treatment Outcome of Abdominal Sacrocolpopexy
title_sort long-term treatment outcome of abdominal sacrocolpopexy
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2796408/
https://www.ncbi.nlm.nih.gov/pubmed/20046422
http://dx.doi.org/10.3349/ymj.2009.50.6.807
work_keys_str_mv AT jeonmyungjae alongtermtreatmentoutcomeofabdominalsacrocolpopexy
AT moonyeojung alongtermtreatmentoutcomeofabdominalsacrocolpopexy
AT junghyunjoo alongtermtreatmentoutcomeofabdominalsacrocolpopexy
AT limkyungjin alongtermtreatmentoutcomeofabdominalsacrocolpopexy
AT yanghyoin alongtermtreatmentoutcomeofabdominalsacrocolpopexy
AT kimseikwang alongtermtreatmentoutcomeofabdominalsacrocolpopexy
AT baisangwook alongtermtreatmentoutcomeofabdominalsacrocolpopexy
AT jeonmyungjae longtermtreatmentoutcomeofabdominalsacrocolpopexy
AT moonyeojung longtermtreatmentoutcomeofabdominalsacrocolpopexy
AT junghyunjoo longtermtreatmentoutcomeofabdominalsacrocolpopexy
AT limkyungjin longtermtreatmentoutcomeofabdominalsacrocolpopexy
AT yanghyoin longtermtreatmentoutcomeofabdominalsacrocolpopexy
AT kimseikwang longtermtreatmentoutcomeofabdominalsacrocolpopexy
AT baisangwook longtermtreatmentoutcomeofabdominalsacrocolpopexy